Patents by Inventor Ryoichi IMAMURA

Ryoichi IMAMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250032534
    Abstract: One drug (preparation) of the present invention is a drug for a reproductive disorder containing a silicon fine particle, an aggregate of silicon fine particles or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of reproductive disorder.
    Type: Application
    Filed: September 12, 2024
    Publication date: January 30, 2025
    Applicant: OSAKA UNIVERSITY
    Inventors: Ryoichi IMAMURA, Hikaru KOBAYASHI, Yuki KOBAYASHI, Shinichiro FUKUHARA, Yusuke INAGAKI, Norio NONOMURA
  • Publication number: 20240304331
    Abstract: Provided is a method for further improving therapeutic effect and cost efficiency by ascertaining cancer type and treatment responsiveness for individual patients. The invention provides a method which includes providing information regarding cancer type of a subject, comprising assessing the cancer type of the subject using a marker relating to the amount of a D-amino acid in blood of the subject, and providing information relating to the cancer type of the subject, based on the assessment results, as well as a system for providing information pertaining to cancer in a subject, which carries out the method.
    Type: Application
    Filed: March 7, 2024
    Publication date: September 12, 2024
    Applicants: Kagami Inc., National Institutes of Biomedical Innovation, Health and Nutrition, Osaka University
    Inventors: Atsunari Kawashima, Norio Nonomura, Ryoichi Imamura, Akinaru Yamamoto, Tomonori Kimura, Masashi Mita
  • Patent number: 11951125
    Abstract: One drug (solid preparation) 100 of the present invention is a drug for a disease of kidney that contains a silicon fine particle, an aggregate of the silicon fine particles, or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of the kidney disease.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: April 9, 2024
    Assignee: OSAKA UNIVERSITY
    Inventors: Hikaru Kobayashi, Yuki Kobayashi, Ryoichi Imamura, Norio Nonomura
  • Publication number: 20220088064
    Abstract: One drug (preparation) of the present invention is a drug for a reproductive disorder containing a silicon fine particle, an aggregate of silicon fine particles or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of reproductive disorder.
    Type: Application
    Filed: November 29, 2019
    Publication date: March 24, 2022
    Applicant: OSAKA UNIVERSITY
    Inventors: Ryoichi IMAMURA, Hikaru KOBAYASHI, Yuki KOBAYASHI, Shinichiro FUKUHARA, Yusuke INAGAKI, Norio NONOMURA
  • Publication number: 20210275578
    Abstract: One drug (solid preparation) 100 of the present invention is a drug for a disease of kidney that contains a silicon fine particle, an aggregate of the silicon fine particles, or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of the kidney disease.
    Type: Application
    Filed: April 21, 2021
    Publication date: September 9, 2021
    Inventors: Hikaru KOBAYASHI, Yuki KOBAYASHI, Ryoichi IMAMURA, Norio NONOMURA
  • Patent number: 11103527
    Abstract: One drug (solid preparation) 100 of the present invention is a drug for a disease of kidney that contains a silicon fine particle, an aggregate of the silicon fine particles, or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of the kidney disease.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: August 31, 2021
    Assignee: Osaka University
    Inventors: Hikaru Kobayashi, Yuki Kobayashi, Ryoichi Imamura, Norio Nonomura
  • Publication number: 20200179439
    Abstract: One drug (solid preparation) 100 of the present invention is a drug for a disease of kidney that contains a silicon fine particle, an aggregate of the silicon fine particles, or a crystal grain of silicon having a hydrogen-generating ability. Hydrogen generated from the silicon fine particle in the drug can contribute to the prevention and/or treatment of the kidney disease.
    Type: Application
    Filed: July 4, 2018
    Publication date: June 11, 2020
    Inventors: Hikaru KOBAYASHI, Yuki KOBAYASHI, Ryoichi IMAMURA, Norio NONOMURA